Three novel investigational hybrid closed-loop insulin delivery systems improve blood glucose and, if approved, will greatly increase options for patients with type 1 diabetes.
Medscape Medical News
Original Article: Three Novel Systems Could Expand 'Hybrid Closed-Loop' Field